ANG - angiogenin Gene
Also Known as ANG1
Species: Sus scrofa
Gene Type: protein coding
Gene ID: 733639
ANG Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001044573.2 | NP_001038038.1 | angiogenin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
angiogenin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-13948 | Angiotensin II human | 99.98% | Unkown | |
| HY-13948A | Angiotensin II human acetate | 99.81% | Unkown | |
| HY-B0561 | Spironolactone | 99.81% | Yes | |
| HY-B0202 | Irbesartan | 99.95% | Yes | |
| HY-B0935 | Benzyl benzoate | Inhibitor | 99.98% | Yes |
| HY-13948B | Angiotensin II human TFA | 98.29% | Unkown | |
| HY-B0202A | Irbesartan hydrochloride | / | Unkown | |
| HY-B0202R | Irbesartan (Standard) | / | Unkown |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P99116 | Faricimab | Inhibitor | 97.97% | Unkown |
Clinical Phase
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-160187 | AAA | Antagonist | 99.52% | Phase 4 |
| HY-P4073 | ANG1005 | 98.83% | Phase 3 | |
| HY-137455 | Terevalefim | Activator | 99.37% | Phase 3 |
| HY-177671 | Zodasiran | Inhibitor | 95.26% | Phase 3 |
| HY-177671A | Zodasiran sodium | Inhibitor | / | Phase 3 |
| HY-109041 | Razuprotafib | 98.0% | Phase 2 | |
| HY-147243 | Ansornitinib | Inhibitor | 98.23% | Phase 2 |
| HY-124397 | N-Acetylcolchinol phosphate | Inhibitor | / | Phase 2 |
Inhibitory Antibodies
(7)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P99546 | Trebananib | Inhibitor | ≥99.0% | Phase 3 |
| HY-P99330 | Vanucizumab | Inhibitor | 95.12% | Phase 2 |
| HY-P99510 | Zansecimab | Inhibitor | ≥95.0% | Phase 2 |
| HY-P990689 | Zifibancimig | Inhibitor | 99.00% | Phase 2 |
| HY-P99036 | Nesvacumab | Inhibitor | 99.11% | Phase 1 |
| HY-P991663 | AMG-780 | Inhibitor | / | Phase 1 |
| HY-P991415 | ASKG-712 | Antagonist | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(63)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12403 | Talfirastide | 99.91% | Yes | |
| HY-P0216 | A 779 | Antagonist | 99.55% | Unkown |
| HY-P1236 | Atrial Natriuretic Peptide (ANP) (1-28), rat, mouse | Inhibitor | 99.55% | Unkown |
| HY-15477 | YS-49 | 99.98% | Unkown | |
| HY-168438 | ERBB agonist-1 | 99.16% | Unkown | |
| HY-N0515 | Ophiopogonin D | 99.80% | Unkown | |
| HY-151483 | TK-129 | Inhibitor | ≥98.0% | Unkown |
| HY-12403A | Talfirastide acetate | 99.76% | Yes | |
| HY-P3136 | TRV055 | 99.47% | Unkown | |
| HY-13948F1 | Angiotensin II human, FAM-labeled | Activator | 99.58% | Unkown |
| HY-N7665 | Prosaikogenin G | 98.35% | Unkown | |
| HY-P2983 | Angiotensin-converting enzyme | / | Unkown | |
| HY-P3136A | TRV055 hydrochloride | Agonist | 98.88% | Unkown |
| HY-N2445 | Flavokawain C | 99.79% | Unkown | |
| HY-P1415A | Norleual TFA | 99.93% | Unkown | |
| HY-13948BS | Angiotensin II human-13C6,15N TFA | 98.39% | Unkown | |
| HY-15477A | YS-49 monohydrate | 99.56% | Unkown | |
| HY-13948F | Biotin-Ahx-Angiotensin II human | 99.86% | Unkown | |
| HY-P10933 | PRO20 | Antagonist | 99.16% | Unkown |
| HY-P1236A | Atrial Natriuretic Peptide (ANP) (1-28), rat, mouse TFA | Inhibitor | 99.32% | Unkown |
| HY-15778A | AVE 0991 sodium salt | Agonist | 99.47% | Unkown |
| HY-N2666 | 5α-Hydroxycostic acid | Inhibitor | 95.17% | Unkown |
| HY-15193B | EMD638683 (S-Form) | Inhibitor | 99.95% | Unkown |
| HY-B0202S | Irbesartan-d4 | Antagonist | 99.46% | Unkown |
| HY-135795 | 1-Cyclohexyl-3-dodecyl urea | Inhibitor | 98.0% | Unkown |
| HY-16707 | CH 5450 | Inhibitor | 98.19% | Unkown |
| HY-172699A | DSPE-PEG3400-ANG | 95.0% | Unkown | |
| HY-B0561S4 | Spironolactone-d6-1 | 99.26% | Unkown | |
| HY-RS00684 | ANG Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W342283 | Diminazene | / | Unkown | |
| HY-109041A | Razuprotafib sodium | / | Unkown | |
| HY-184265 | Mito-Esculetin | / | Unkown | |
| HY-102093A | ZD 7155 | / | Unkown | |
| HY-103247 | EMD 66684 | Antagonist | / | Unkown |
| HY-105506 | EXP-7711 | Antagonist | / | Unkown |
| HY-108120 | L-162537 | Inhibitor | / | Unkown |
| HY-114164E | Rabbit Thrombin | / | Unkown | |
| HY-121313 | Embusartan | Antagonist | / | Unkown |
| HY-129412 | A-74273 | Inhibitor | / | Unkown |
| HY-131162 | Chymase | Activator | / | Unkown |
| HY-142694 | DCN1-UBC12-IN-2 | Inhibitor | / | Unkown |
| HY-160043 | AL6 aptamer sodium | / | Unkown | |
| HY-162729 | LSD1-IN-34 | Inhibitor | / | Unkown |
| HY-163859 | LSD1-IN-33 | Inhibitor | / | Unkown |
| HY-169026 | DCN1-IN-2 | Inhibitor | / | Unkown |
| HY-172698 | DSPE-PEG1000-ANG | / | Unkown | |
| HY-172699 | DSPE-PEG2000-ANG | / | Unkown | |
| HY-172700 | DSPE-PEG5000-ANG | / | Unkown | |
| HY-19165 | CI-996 | Antagonist | / | Unkown |
| HY-19200 | RB-105 | Inhibitor | / | Unkown |
| HY-B0202S2 | Irbesartan-d6-1 | / | Unkown | |
| HY-P0216A | A-779 TFA | Antagonist | / | Unkown |
| HY-P10597 | Angiotensin II type 1 receptor (181-187) | Activator | / | Unkown |
| HY-P11389 | (Sar1,Gly8)-Angiotensin II | Antagonist | / | Unkown |
| HY-P1415 | Norleual | / | Unkown | |
| HY-P3545 | 5-Valine-angiotensin I | Activator | / | Unkown |
| HY-167886 | GA 0113 | Antagonist | / | Unkown |
| HY-180796 | PKM2 agonist-1 | Agonist | / | Unkown |
| HY-B0202AS | Irbesartan-d7 hydrochloride | / | Unkown | |
| HY-B0202S3 | Irbesartan-d7 | / | Unkown | |
| HY-RS16832 | Ang Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS23274 | Ang Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24191 | Agt Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P992323 | BI-836880 | Inhibitor | / | Unkown |